SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001494650-22-000037
Filing Date
2022-04-26
Accepted
2022-04-26 08:17:50
Documents
16
Period of Report
2022-04-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K optn-20220425.htm   iXBRL 8-K 44778
2 EX-10.1 cooperationagreement.htm EX-10.1 131520
3 EX-99.1 pressrelease8-kapril252022.htm EX-99.1 8281
7 imagea.jpg GRAPHIC 33411
8 optn-20220425_g1.jpg GRAPHIC 10067
  Complete submission text file 0001494650-22-000037.txt   430495

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT optn-20220425.xsd EX-101.SCH 1902
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT optn-20220425_lab.xml EX-101.LAB 25848
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT optn-20220425_pre.xml EX-101.PRE 13581
10 EXTRACTED XBRL INSTANCE DOCUMENT optn-20220425_htm.xml XML 12131
Mailing Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067
Business Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067 267-364-3500
OptiNose, Inc. (Filer) CIK: 0001494650 (see all company filings)

IRS No.: 421771610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38241 | Film No.: 22851858
SIC: 2834 Pharmaceutical Preparations